Aliases & Classifications for Erythroplakia

MalaCards integrated aliases for Erythroplakia:

Name: Erythroplakia 20
Erythroplasia 70

Classifications:



External Ids:

UMLS 70 C0014818

Summaries for Erythroplakia

MalaCards based summary : Erythroplakia, also known as erythroplasia, is related to leukoplakia and oral leukoplakia. An important gene associated with Erythroplakia is ALDH1A1 (Aldehyde Dehydrogenase 1 Family Member A1), and among its related pathways/superpathways are Glucose / Energy Metabolism and Neural Stem Cell Differentiation Pathways and Lineage-specific Markers. The drugs Metformin and Hypoglycemic Agents have been mentioned in the context of this disorder. Affiliated tissues include tongue, salivary gland and cervix.

Wikipedia : 73 Erythroplakia is a clinical term to describe any erythematous (red) area on a mucous membrane, that... more...

Related Diseases for Erythroplakia

Graphical network of the top 20 diseases related to Erythroplakia:



Diseases related to Erythroplakia

Symptoms & Phenotypes for Erythroplakia

Drugs & Therapeutics for Erythroplakia

Drugs for Erythroplakia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):


# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Metformin Approved Phase 2 657-24-9 14219 4091
2 Hypoglycemic Agents Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 M4OC-Prevent: Metformin for Oral Cancer Prevention Active, not recruiting NCT02581137 Phase 2 Metformin Hydrochloride
2 Natural History of Oral Cancer Precursors Completed NCT00179361
3 Fluorescence &Amp; Reflectance Imaging to Detect Oral Neoplasia Active, not recruiting NCT00542373

Search NIH Clinical Center for Erythroplakia

Genetic Tests for Erythroplakia

Anatomical Context for Erythroplakia

MalaCards organs/tissues related to Erythroplakia:

40
Tongue, Salivary Gland, Cervix, Uterus, Brain, Breast, Skin

Publications for Erythroplakia

Articles related to Erythroplakia:

(show top 50) (show all 490)
# Title Authors PMID Year
1
Diabetes mellitus and oral cancer/oral potentially malignant disorders: A systematic review and meta-analysis. 61
31994293 2021
2
The prevalence of human leucocyte antigen and human papillomavirus DNA in penile intraepithelial neoplasia in England 2011-2012. 61
33576716 2021
3
Malignant transformation of oral potentially malignant disorders in Taiwan: An observational nationwide population database study. 61
33655959 2021
4
Knowledge and Practice Regarding Oral Cancer: A Study Among Dentists in Jakarta, Indonesia. 61
33612266 2021
5
Successful GaAlAs low-level laser therapy of self-inflicted thermal burns of the palate. 61
33747516 2021
6
Oral leukoplakia and erythroplakia in young patients: a systematic review. 61
33187936 2021
7
Evaluation of quality of life in patients surgically treated for potentially malignant oral lesions. 61
33402597 2020
8
Prevalence of oral mucosal normal variations and lesions in a middle-aged population: a Northern Finland Birth Cohort 1966 study. 61
33298037 2020
9
Recognition of oral potentially malignant disorders and transformation to oral cancer. 61
33109976 2020
10
Recognition of oral potentially malignant disorders and transformation to oral cancer. 61
33048859 2020
11
Differences in the Incidence of Pathologic Lesions on the Oral Mucosa in Patients Undergoing Hemodialysis vs Renal Organ Transplant Recipients Subjected to Long-term Pharmacologic Immunosuppressive Therapy. 61
32222390 2020
12
Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. 61
33128420 2020
13
Profiling risk factors of micro-invasive carcinoma within oral potentially malignant disorders: a cross-sectional study. 61
32902677 2020
14
Proliferative verrucous leukoplakia and erythroplakia are probably the disorders with the highest rate of malignant transformation. 61
32471555 2020
15
[Research progress of oral erythroplakia]. 61
32486574 2020
16
Efficacy of topical photodynamic therapy in the treatment of Erythroplasia of Queyrat. 61
32655845 2020
17
Comparison of Salivary and Serum Alkaline Phosphates Level and Lactate Dehydrogenase Levels in Patients with Tobacco Related Oral Lesions with Healthy Subjects - A Step Towards Early Diagnosis. 61
32334459 2020
18
Oral lichen planus - case report. 61
33544810 2020
19
Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype. 61
31803979 2020
20
Photodynamic Therapy for Photodamage, Actinic Keratosis, and Acne in the Cosmetic Practice. 61
31779937 2020
21
Erythroplasia of Queyrat treated with methyl aminolevulinate-photodynamic therapy. 61
27905695 2020
22
Podoplanin and ABCG2 expression in oral erythroplakia revisited: Potential evidence for cancer stem cells driving the process of field cancerization. 61
31300272 2020
23
Cancer stem cell markers ALDH1 and Bmi1 expression in oral erythroplakia revisited: Implication for driving the process of field cancerization. 61
31444928 2020
24
Oral Potentially Malignant Disorders. 61
31735231 2020
25
Oral potentially malignant disorders: clinical-pathological study of 684 cases diagnosed in a Brazilian population. 61
31880285 2020
26
Oral potentially malignant disorders: clinical diagnosis and current screening aids: a narrative review. 61
30921006 2020
27
[Modern perspectives of oral squamous cell carcinoma]. 61
32593268 2020
28
Medical practitioners' educational competence about oral and oropharyngeal carcinoma: a systematic review and meta-analysis. 61
31785865 2020
29
Squamous cell carcinoma of the head and neck - screening in patients who misuse alcohol and tobacco in Switzerland: a prospective pilot study. 61
31594715 2019
30
Ingenol mebutate therapy in erythroplasia of Queyrat: a new approach. 61
31804047 2019
31
WNT signalling pathway in oral lesions. 61
31740880 2019
32
[Potentially malignant disorders of the oral mucosa]. 61
32237647 2019
33
Retrospective analysis of oral erythroplakia focused on multiple and multifocal malignant behavior. 61
31188512 2019
34
Smokeless tobacco use and oral neoplasia among urban Indian women. 61
31348589 2019
35
Oral Epithelial Dysplasia and Premalignancy. 61
30887394 2019
36
Dermatoscopic findings of penile intraepithelial neoplasia: Bowenoid papulosis, Bowen disease and erythroplasia of Queyrat. 61
30585302 2019
37
Premalignant male genital dermatoses. 61
31922098 2019
38
Bibliometric analysis of the top-cited articles on oral erythroplakia and leukoplakia. 61
31006140 2019
39
In situ squamous cell carcinoma of male and female external genitalia. 61
31922109 2019
40
Oral Potentially Malignant Disorders and Squamous Cell Carcinoma at the Tongue: Clinicopathological Analysis in a Thai Population. 61
31618783 2019
41
Salivary inflammatory proteins in patients with oral potentially malignant disorders. 61
31516665 2019
42
White, red, and mixed lesions of oral mucosa: A clinicopathologic approach to diagnosis. 61
31090142 2019
43
Assessing Oral Cancer Awareness Among Dental Students. 61
29446005 2019
44
"SKILL TO KILL" - Oral cancer and potentially premalignant oral epithelial lesions (PPOELs): A survey approach. Emerging of a new system and professionals. 61
31516232 2019
45
Expression of cluster differentiation-44 stem cell marker in grades of oral epithelial dysplasia: A preliminary study. 61
31516224 2019
46
Accuracy of dermoscopy in distinguishing erythroplasia of Queyrat from common forms of chronic balanitis: results from a multicentric observational study. 61
30468529 2019
47
Erythroplasia of Queyrat treated with imiquimod 5% cream: The necessity of regimen guidelines. 61
30997072 2019
48
Impact of oral potentially malignant disorder subtypes on all-cause and cause-specific mortality in males. 61
30592115 2019
49
Erythematous and Vascular Oral Mucosal Lesions: A Clinicopathologic Review of Red Entities. 61
30693460 2019
50
Micronuclei in Exfoliated Oral Epithelial Cells in Tobacco Users and Controls with Various Oral Lesions: A Study from Gujarat, India. 61
30906725 2019

Variations for Erythroplakia

Expression for Erythroplakia

Search GEO for disease gene expression data for Erythroplakia.

Pathways for Erythroplakia

Pathways related to Erythroplakia according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.45 ALDH1A1 ABCG2
2 10.52 BMI1 ABCG2

GO Terms for Erythroplakia

Sources for Erythroplakia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 20-May-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....